 Denali Therapeutics Inc NASDAQ:DNLI was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 8,910,000 shares, a decrease of 5.9 from the March 15th total of 9,469,800 shares. Currently, 12.4 of the companys stock are sold short. Based on an average ... 